A clinical stage biopharmaceutical company developing small molecule precision medicines for the treatment of kidney and metabolic diseases, with lead programs in APOL1 kidney disease, phenylketonuria, chronic kidney disease, and Pompe disease.
South San Francisco, CA, United States~141 employeesFounded Jan 2017Website